Introduction
============

Mortality from coronary heart disease (CHD) caused by atherosclerosis is increased sharply in both industrial countries and developing countries.[@b1-vhrm-10-523] Prevalence of atherosclerotic CHD has been increasing yearly and has been declared by the World Health Organization (WHO) as a global threat.[@b2-vhrm-10-523] It is estimated that 1.9 billion people, or one-third of the world's population, are affected by this disease.[@b2-vhrm-10-523] In Indonesia, morbidity and mortality from CHD are likely to increase and the mortality rate has reached 50%.[@b2-vhrm-10-523]

Risk factors for atherosclerosis include dyslipidemia, free radicals, endothelial dysfunction, and inflammation.[@b3-vhrm-10-523] Increased levels of cholesterol in blood, especially low-density lipoprotein (LDL) cholesterol, is harmful because of the peroxidation process (auto-oxidation) of lipids which are exposed to oxygen. Lipid peroxidation is a chain reaction that continues to produce reactive oxygen species (ROS) such as OH^−^, RO, and hydrogen peroxide (H~2~O~2~)[@b4-vhrm-10-523]. H~2~O~2~ causes nuclear factor kappa beta (NF-κB) activation. NF-κB is a transcription factor that plays an important role in controlling various biological effects such as inflammation, immune defense mechanism, cell proliferation and differentiation, tumorigenesis, and cell apoptosis.[@b5-vhrm-10-523] NF-κB plays an important role in atherosclerosis because of the chronic inflammatory process that occurs throughout atherosclerosis.[@b6-vhrm-10-523]

NF-κB activation products initiate the process of atherosclerosis with endothelial dysfunction, occurrence of platelet adhesion, and the migration and proliferation of smooth muscle cells.[@b7-vhrm-10-523] Inducible nitric oxide synthase (iNOS) expression is increased in macrophages and smooth muscle cells at the early and advanced stages of atherosclerotic lesions. Inflammation plays a crucial role in the development of atherosclerotic lesions affecting coronary arteries. iNOS plays an important role in inflammation through the fast and high production of prostanoid and NO, both of which have proatherosclerotic effects.[@b8-vhrm-10-523]

Active metabolism of cells happens in inflammation. The metabolism of active cells enormously increases the demand for oxygen and the reduction of oxygen supply, finally resulting in hypoxia.[@b9-vhrm-10-523] The rise of hypoxia that takes place in vessel walls is also caused by the thickening of arterial walls in atherosclerosis, which disturbs the diffusion of oxygen.[@b10-vhrm-10-523] Hypoxia is strongly associated with angiogenesis and formation of thrombus. The effect of hypoxia is mediated by macrophage, which infiltrate the thrombus. A macrophage is a cell that has the ability to immediately alter not only anaerobic metabolism but also aerobic metabolism (glycolytic turnover). This elevates the oxygen demand.[@b11-vhrm-10-523] Hypoxia promotes the adaptation of cells through the activation of hypoxia-inducible factor-1α (HIF-1α).

HIF-1α is a transcription factor that regulates glycolysis, angiogenesis, and cell survival.[@b12-vhrm-10-523] HIF-1α in normal oxygen conditions is unstable and cannot be detected due to hydroxylation. In hypoxic conditions, HIF-1α is stable and undergoes translocation from cytoplasm to nucleus and binds to specific promoter hypoxia response element sites that regulate classics genes for responsiveness to hypoxia.[@b11-vhrm-10-523]

The possible role of HIF-1α in atherosclerosis is supported by the presence of intraplaque angiogenesis, which is an implication of some HIF-responsive genes in atherosclerosis, such as vascular endothelial growth factor (VEGF), endothelin-1, and matrix-metalloproteinase-2.[@b13-vhrm-10-523]--[@b15-vhrm-10-523] VEGF binds to tyrosine kinase receptors and becomes VEGF receptor-1 (VEGFR-1), which is also known as Flt (fms-like tyrosine kinase-1). VEGFR-1 is expressed in early vascular development and postnatal angiogenesis. VEGFR-1 is also expressed in inflammatory cells such as monocytes and macrophages, which coordinate inflammation and become an early marker of pathological angiogenesis associated with atherosclerosis.[@b12-vhrm-10-523] Research conducted by Sluimer et al[@b16-vhrm-10-523] in 2008 suggested that hypoxia is strongly associated with angiogenesis and thrombus formation. Atherosclerosis shows the process of vasa vasorum angiogenesis to be extensive, fragile, and immature, and associated with growth and instability of atherosclerotic plaque.[@b17-vhrm-10-523],[@b18-vhrm-10-523] The vasa vasorum become interesting to discuss for their unique function, because the vasa vasorum are vessels supplying blood to the vessels, or in other words, vessels located inside vessels.[@b19-vhrm-10-523]

Collection of evidence related to plaque vasa vasorum angiogenesis and its contribution to the progressivity of atherosclerosis and development of lesion instability demonstrates the importance of controlling angiogenesis through anti-angiogenic agents.[@b20-vhrm-10-523] Because of ROS involvement from the beginning of pathogenicity of atherosclerosis, when the vasa vasorum angiogenesis mechanism is involved, the use of antioxidant as an anti-angiogenic agent is an essential consideration.

Mangosteen pericarp extract (*Garcinia mangostana* Linn) is one potential antioxidant agent. Bioactive content of the skin of mangosteen has anti-inflammatory, antioxidant, and antihistamine effects, as well as other pharmacological activities. Some of the major compounds in mangosteen skin that are reported are xanthones.[@b21-vhrm-10-523] Mangosteen pericarp extract is proven to inhibit NF-κB activation in rat models with administration of a hypercholesterol diet.[@b22-vhrm-10-523] Mangosteen pericarp extract possess high antioxidant activity that inhibits cellular damage caused by ROS, so NF-κB remains in an inactive state in cytoplasm. Research to prove whether or not mangosteen pericarp ethanolic extract (MPEE) may prevent vasa vasorum angiogenesis through the inhibition of H~2~O~2~, HIF-1α, NF-κB, and iNOS expressions in Wistar strain *Rattus norvegicus* rats with hypercholesterol diet administration has not yet been undertaken. The purpose of this study is to prove the anti-angiogenic vasa vasorum effect of mangosteen pericarp extract through the inhibition of H~2~O~2~, HIF-1α, NF-κB, and iNOS in Wistar strain *R. norvegicus* rats administered a hypercholesterol diet.

Methods
=======

Study group
-----------

Twenty male *R. norvegicus* Wistar strain rats, 8 weeks old, with 150--200 g body weight, were obtained from the Pharmacology Laboratory of Faculty of Medicine, Brawijaya University, Malang, Indonesia. These rats were divided into five groups: negative control group (normal diet group), positive control group (hypercholesterol-diet-given group), and groups with both hypercholesterol diet and administration of treated MPEE at a variety of doses: 200, 400, and 800 mg/kg body weight (BW). The extraction process took place in the Central Laboratory of Pharmacology, Faculty of Medicine, Brawijaya University. Mangosteen pericarp was extracted using ethanol solution and given to the rat models by sonde every day. Hypercholesterol diet in this study was a common food for the rat models with addition of 2% cholesterol, 0.2% cholic acid, and 5% lard, which was given at 30 g daily ad libitum for 3 months, obtained from the Pharmacology Laboratory of Faculty of Medicine, Brawijaya University. The measurement of parameters of this study was conducted at the Biomedical Laboratory and Central Laboratory of Biological Sciences, Brawijaya University after obtaining ethical clearance assessment by the Health Research Ethics Committee with this given number: 054 A/EC/KEPK/02/2013.

Biochemical tests
-----------------

### H~2~O~2~ measurement

H~2~O~2~ levels were measured in rat plasma using a Colorimetric Hydrogen Peroxide Kit (Assay Design) (Abcam^®^, Cambridge, UK) and observed at 570 nm with an enzyme-linked immunosorbent assay (ELISA) reader (Life Sciences Advanced Technologies, Inc., St Petersburg, FL, USA).

### HIF-1α, NF-κB, and iNOS measurement

HIF-1α, NF-κB, and iNOS were measured by immunofluorescence of aortic tissues that were previously fixed with PHEMO buffer (68 mM PIPES, 25 mM, HEPES, pH 6.9, 15 mM EGTA, 3 mM MgCl2, 10% \[v/v\] dimethyl sulfoxide containing 3.7% formaldehyde and 0.05% glutaraldehyde) and were processed by imumunofluoresence double labeling with anti-rat antibody HIF-1α using rhodamine secondary antibody and anti-rat antibody NF-κB using fluorescein isothiocyanate secondary antibody (BIOS Inc., Boston, MA, USA). iNOS in smooth muscle cell derived from anti-rat iNOS antibody was colored by fluorescein isothiocyanate (FITC) and α-actin was colored by rhodamine secondary antibody (BIOS Inc.). These three parameters were observed with confocal laser scanning microscopy (Olympus Corporation, Tokyo, Japan) and were quantitatively analyzed using Olympus FluoView software (version 1.7A; Olympus Corporation).

### Angiogenesis vasa vasorum measurement

Vasa vasorum angiogenesis measurement was done by measuring levels of aortic VEGFR-1 by ELISA (Abcam). Histopathological description of vasa vasorum was observed by hematoxylin and eosin staining and microscope BX 53 (Olympus Corporation) at 600× magnification. The amount of vasa vasorum was identified from the characteristic of aortic lumen which contains erythrocyte.

Statistical analysis
--------------------

This study used analysis of variance (ANOVA) test to determine the effect of MPEE on the reduction of VEGFR-1, H~2~O~2~, HIF-1α, NF-κB, and iNOS in Wistar strain *R. norvegicus* rats with hypercholesterol administration. Analysis was continued with post hoc test with Duncan method to detect the differences of parameters among treatment groups. SPSS software (v 20; IBM Corporation, Armonk, NY, USA) was used for data analysis.

Results
=======

Levels of VEGFR-1 in the various treatment groups ranged from 10.650 to 18.239 pg/mL. The negative control group had lower levels of VEGFR-1 (10.650--15.440 pg/mL), while the hypercholesterol groups treated with various doses of MPEE had VEGFR-1 levels from 15.728--18.239 pg/mL. The formation of VEGFR-1 is inhibited by the increased doses of MPEE. ANOVA test with 95% confidence interval showed that the addition of MPEE had a significant effect (*P*=0.04) on the reduction of VEGFR-1 levels. Post hoc Duncan test (pay attention to a, b, c notations in the $\overline{x} \pm {SD}$ column) showed a significant difference in VEGFR-1 levels between the hypercholesterol group without MPEE, the normal diet group, and the hypercholesterol group that received MPEE at the 800 mg/kg BW dose.

The counted number of vasa vasorum ranged from one to 23. In the negative control group, the amount of vasa vasorum was lower than in the hypercholesterol group (±2--6), while the hypercholesterol groups with MPEE had an estimated number of vasa vasorum from one to 23. Vasa vasorum, descriptively, are less likely to form with increasing amounts of MPEE. ANOVA test with 95% confidence interval showed that the addition of MPEE played a significant role (*P*=0.00) in decreasing the amount of vasa vasorum. Post hoc Duncan test showed a significant difference in vasa vasorum number between the hypercholesterol group without MPEE, the normal diet group, and the hypercholesterol group that received MPEE at the 800 mg/kg BW dose.

H~2~O~2~ levels in the various treatment groups ranged from 0.132 to 1.968 pg/mL. In the negative control group, the H~2~O~2~ level was lower compared to the hypercholesterol groups with various doses of MPEE (0.132--0.237 pg/mL compared to 0.214--1.968 pg/mL). H~2~O~2~ is more difficult to form with the increased doses of MPEE. ANOVA test with 95% confidence interval showed that the addition of MPEE played a significant role (*P*=0.01) in decreasing the levels of H~2~O~2~. Post hoc Duncan test showed a significant difference of H~2~O~2~ levels between the hypercholesterol group without MPEE, the normal diet group, the hypercholesterol group that received MPEE at the 400 mg/kg BW dose, and the hypercholesterol group that received MPEE at the 800 mg/kg BW dose.

HIF1-α expression in the various treatment groups ranged from 508.20 to 1,555.59 arbitrary unit (au) can be seen in [Figure 1](#f1-vhrm-10-523){ref-type="fig"}. In the negative control group, HIF1-α expression was lower (612.98--1,298.87 au), whereas the hypercholesterol groups given MPEE at various doses had a range of HIF1-α expression from 508.20--1,555.59 au. HIF1-α, descriptively, are less likely to form with higher doses of MPEE. ANOVA test with 95% confidence interval showed that the addition of MPEE played a significant role (*P*=0.01) in decreasing HIF1-α expression. Post hoc Duncan test showed a significant difference in HIF1-α expressions between the hypercholesterol group without MPEE, the normal diet group, the hypercholesterol group that received MPEE at the 400 mg/kg BW dose, and the hypercholesterol group that received MPEE at the 800 mg/kg BW dose.

The expression of NF-κB in the different treatment groups ranged from 1,132.32 to 2,146.59 au can be seen in [Figure 2](#f2-vhrm-10-523){ref-type="fig"}. The negative control group had lower expression of NF-κB (1,364.47--2,146.59 au), whereas the expression of NF-κB in groups with hypercholesterol and MPEE administration at various doses ranged from 1,132.32 to 1,982.18 au. NF-κB, descriptively, are less likely to form with increasing doses of MPEE. ANOVA test with 95% confidence interval showed that the higher doses of MPEE had a significant effect (*P*=0.01) on the reduction of NF-κB expression. Post hoc Duncan test showed a significant difference of NF-κB expression between the hypercholesterol group without MPEE, the normal diet group, the hypercholesterol group that received MPEE at the 400 mg/kg BW dose, and the hypercholesterol group that received MPEE at the 800 mg/kg BW dose.

iNOS expression in the various treatment groups ranged from 309.85 to 1,458.66 au can be seen in [Figure 3](#f3-vhrm-10-523){ref-type="fig"}. In the negative control group, iNOS expression was lower (736.25--987.89 au) than that in the hypercholesterol groups with the addition of various doses of MPEE (309.85--1,458.66 au). iNOS, descriptively, are less likely to form with higher doses of MPEE. ANOVA test with 95% confidence interval showed that the addition of MPEE played a significant role (*P*=0.01) in decreasing iNOS expression. Post hoc Duncan test showed a significant difference in iNOS expressions between the hypercholesterol group without MPEE, the normal diet group, the hypercholesterol group that received MPEE at the 400 mg/kg BW dose, and the hypercholesterol group that received MPEE at the 800 mg/kg BW dose.

Discussion
==========

Vasa vasorum angiogenesis that occurs in Wistar strain *R. norvegicus* that are given a hypercholesterol diet is closely related to vascular oxidative stress. Oxidative stress is a condition in which there is an imbalance between oxidant and antioxidant. The increase of oxidative stress on arterial walls contributes to atherogenesis. Post hoc Duncan test showed a significant difference in VEGFR-1 levels and number of vasa vasorum between normal and hypercholesterol diet groups. This result of Post Hoc Test reveals that angiogenesis involved in the increased level of H~2~O~2~, HIF-1α, NF-κB, and iNOS levels in hypercholesterol groups.

A certain amount of antioxidant is required to maintain the stability between oxidative stress and antioxidant to minimize cellular damage. A variety of antioxidant substances may prevent or significantly inhibit the oxidation process. Antioxidants are substances that become effective against oxidative damage.[@b23-vhrm-10-523] This study used MPEE that contains antioxidant which plays a role in vasa vasorum anti-angiogenesis.

Based on data shown in this study, only a small amount of vasa vasorum can be found not only in hypercholesterol groups with 200, 400, and 800 mg/kg BW of MPEE, but also in the normal diet group. In the hypercholesterol group without administration of MPEE, many vasa vasorum were formed ([Figure 4](#f4-vhrm-10-523){ref-type="fig"}). ANOVA analysis affirms that MPEE administration can significantly decrease vasa vasorum angiogenesis in hypercholesterol Wistar strain *R. norvegicus*. Inhibition of VEGFR-1 levels by MPEE is followed by a decrease in the number of formations of vasa vasorum in hypercholesterol Wistar strain *R. norvegicus*. MPEE contains a variety of antioxidants, some of which are xanthones such as alpha, beta, and gamma mangosteen. The antioxidant component of mangostin from mangosteen pericarp has been proven to play a role in lipid peroxidation by donating hydrogen atoms and effectively inhibiting activity of lipid radicals.[@b24-vhrm-10-523] Data from this study assert that significant differences between VEGFR-1 levels can be explained by the dose of MPEE administered. The negative effect of MPEE doses on VEGFR-1 levels enables higher doses of MPEE to strongly reduce VEGFR-1 levels. Post hoc Duncan test revealed that there was no significant difference in VEGFR-1 levels between the hypercholesterol groups with 200, 400, and 800 mg/kg BW of MPEE and the normal diet group. The same can be seen in the amount of vasa vasorum; thus it can be stated that an 800 mg/kg BW dose of MPEE is the most optimal dose among those used in this study. According to studies that used MPEE in animal models of atherosclerosis, an 800 mg/kg BW dose of MPEE is the best dosage for lowering proatherosclerosis markers such as tumor necrosis factor alpha (TNF-α), NF-κB, NO, SOD (superoxide dismutase), and MDA (malondialdehyde).[@b25-vhrm-10-523],[@b26-vhrm-10-523]

The inhibitory effect of vasa vasorum angiogenesis by MPEE in this study was verified by the reduction of H~2~O~2~, HIF-1α, NF-κB, and iNOS levels. ANOVA test results showed that the administration of MPEE played a significant role in reducing the levels of H~2~O~2~, HIF-1α, NF-κB, and iNOS levels in hypercholesterol Wistar strain rats. Mangostin has been reported to effectively protect LDL from lipid peroxidation induced by Cu^2+^ and peroxyl radicals.[@b24-vhrm-10-523] The structure of phenol in mangosteen skin acts as a conventional free radical scavenger in in vitro systems. The ability of mangosteen as a scavenger against various free radicals has been revealed in various studies; one of the free radicals is 2,2-diphenyl-1-picrylhydrazyl radical. Hydroxyl radical scavenging activity of xanthones isolated from mangosteen rind powder have been affirmed. α-mangostin displayed scavenging activity against hydroxyl radicals.[@b27-vhrm-10-523] The ability of mangosteen as a scavenger against hydroxyl radicals has also been observed.[@b28-vhrm-10-523] Activity of α-mangostin and its synthetic derivatives was also found to prevent the decrease of α-tocopherol consumption induced by LDL oxidation.[@b23-vhrm-10-523] Vascular antioxidant is necessary for intracellular and extracellular protection against radical electrons. In the context of oxidative modification hypothesis, antioxidant protection against LDL in extracellular regions becomes a focus of attention because of potential proatherogenic activity of oxidized LDL (oxLDL) and accumulation of oxLDL, which is considered as a sign of atherosclerosis.[@b30-vhrm-10-523],[@b31-vhrm-10-523]

NF-κB was more difficult to form at higher doses of MPEE in this study. In this study, ROS, especially H~2~O~2~, triggers activation of NF-κB. MPEE with bioactive antioxidant ability plays a role in lowering levels of H~2~O~2~ so that NF-κB activation can be inhibited. Mangosteen rind extract has shown potency as an antioxidant.[@b32-vhrm-10-523] Furthermore, a study of antioxidant activity of mangosteen pericarp extract was conducted using water extracts, 50% and 95% ethanol, and ethyl acetate.[@b33-vhrm-10-523] The method used was the capture of 2,2-diphenyl-1-picrylhydrazyl free radical. Results of this study showed that all extracts had potency as free radical scavengers. This is in line with the results of this study, in which ethanol extract was used.

NF-κB is a transcription factor that regulates inflammatory processes. Active metabolism of cells occurs when there is an inflammation, which causes high oxygen demand and the reduction of oxygen supply.[@b9-vhrm-10-523] Elevation of hypoxia in vessel walls is also caused by the thickening of arterial walls that disturbs the diffusion of oxygen.[@b10-vhrm-10-523] HIF-1α activation is a consequence of hypoxia. In this study, hypoxia was induced by inflammatory processes as a result of NF-κB activation, thus contributing to activation of HIF-1α. Hypoxia is strongly associated with angiogenesis and thrombus formation. Effects of hypoxia are mediated by macrophages which infiltrate the thrombus. A macrophage is a cell that has the ability to immediately alter the metabolism in anaerobic and aerobic condition. This causes the increase of oxygen demand.[@b11-vhrm-10-523] When there is hypoxia, cells will adapt to this situation by activating HIF-1α. Furthermore, HIF-1α will stimulate the expression of proangiogenesis genes including VEGFR-1.

Effects of free radicals generated from hypercholesterolemia through the increase of NO from iNOS cause a decrease of antioxidant activity and vulnerability of mitochondria. Antioxidants in MPEE will react with oxidants, thus reducing oxidant capacity to cause damage. Oxygen radicals react with cellular phospholipids and proteins that cause lipid peroxidation and oxidation of thiol groups with membrane changes and dysfunction of various cellular proteins. Supply of antioxidants and capacity of enzymes are significantly reduced following ischemia and reperfusion. Loss of key antioxidant enzymes will decrease supply of myocardial antioxidant. Decreased antioxidant defense cannot provide protection against increase in activity of free radicals and oxidative stress. Based on the results shown in [Table 1](#t1-vhrm-10-523){ref-type="table"}, higher doses of MPEE will result in lower average levels of iNOS. MPEE at doses of 200 mg/kg BW, 400 mg/kg BW, and 800 mg/kg BW is proven to decrease levels of iNOS from rats that have been treated with a hypercholesterol diet. MPEE doses of 200 mg/kg BW, 400 mg/kg BW, and 800 mg/kg BW can significantly reduce levels of NO and TNF-α in an atherosclerosis group.[@b22-vhrm-10-523]

Mangosteen pericarp extract acts as an antioxidant and anti-inflammatory substance that is able to reduce iNOS level and which is potentially proatherosclerotic. Skin of mangosteen contains xanthone, which acts as a powerful free radical scavenger and antioxidant against superoxide anions, hydroxyl, and peroxyl radicals. Xanthone and its derivatives have been shown to have beneficial effects on several cardiovascular diseases, including ischemic heart disease, atherosclerosis, hypertension, and thrombosis.[@b21-vhrm-10-523] Xanthone has a protective effect on the cardiovascular system due to its nature as an antioxidant, anti-inflammatory, and antithrombotic agent that inhibits platelet aggregation. Xanthone compounds were found to inhibit oxLDL.[@b18-vhrm-10-523] Xanthone acts as an antioxidant because of its levels of α-mangostin and γ-mangostin. α-mangostin is a derivative of xanthone that is most abundant in the skin of mangosteen and is known to have potential phytochemical activity. Antioxidant capacity of α-mangostin reached an average of 53.5% in a study with mangosteen phenolic extract.[@b34-vhrm-10-523] It has been confirmed that, as antioxidants, xanthones play a role in inhibiting oxidation of LDL into oxLDL that binds into scavenger receptor-A in macrophages, thus preventing formation of oxLDL.[@b35-vhrm-10-523] When linked to pathogenesis of atherosclerosis, inhibited oxLDL formation will also reduce levels of NO produced by iNOS, because redox-sensitive processes are decreased and ROS production is also inhibited.

MPEE has been found to show radical scavenging activity. α- and γ-mangostin performed antioxidant activity with the use of the ferric thiocyanate method.[@b36-vhrm-10-523] It has also been confirmed that α-mangostins can lower LDL induced by copper oxidation or peroxyl radicals and can also reduce consumption of α-tocopherol induced by oxLDL.[@b36-vhrm-10-523] Ethanol extract of mangosteen pericarp showed significant antioxidant activity in one study, that is proven by inhibition of DPPH radical formation by 50%.[@b37-vhrm-10-523] Furthermore, extracts of *G. mangostana* significantly reduced ROS process in polymorphonuclear leucocytes.[@b37-vhrm-10-523]

It has been shown that iNOS which is stimulated in inflammatory conditions plays a role in pathogenesis of atherosclerosis by the production of NO. Inhibition of NO production has potential therapeutic value in inflammation treatment. It was verified that xanthone, especially that produced by α- and γ-mangostin, evidently blocks the lipopolysaccharides that stimulate NO production.[@b38-vhrm-10-523] It has also been stated that rats induced with a hypercholesterol diet and with higher levels of NO were able to reduce NO after being given MPEE.[@b25-vhrm-10-523] Decline in levels of NO is caused by inhibition of iNOS expression. MPEE has also been confirmed to inhibit other proinflammatory cytokines, such as TNF-α and NF-κB. Results of several studies and theories which are discussed previously are consistent with the finding of our study, that mangosteen pericarp extract is proven capable of inhibiting NO produced by iNOS enzyme. MPEE's role as an antioxidant and anti-inflammatory agent in this study was determined to lessen vasa vasorum angiogenesis in hypercholesterol rats.

Conclusion
==========

Ethanolic extract of mangosteen pericarp (*G. mangostana* Linn) can lower vasa vasorum angiogenesis through H~2~O~2~, HIF-1α, NF-κB, and iNOS inhibition in Wistar strain *R. norvegicus* with a hypercholesterol diet. The antioxidant contained in MPEE has been proven to be involved in vasa vasorum anti-angiogenesis processes. Mangosteen pericarp extract contains a variety of xanthone antioxidants, α-, β-, and γ-mangostin. A dose of 800 mg/kg BW of MPEE was effective in vasa vasorum anti-angiogenesis in rats by administration of a hypercholesterol diet. It is recommended that further research explore the benefits of MPEE with other parameters to provide more explanation about the mechanism of MPEE as an agent against vasa vasorum antiangiogenesis in hypercholesterol rat models.
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![Immunofluorescence staining of HIF-1α in SMC, labeled with α-actin.\
**Notes:** (**A**) α-actin with FITC. The color green shows the expression of α-actin (marker SMC). (**B**) HIF-1α rhodamine. Red shows HIF-1α expression. (**C**) Double stained α-actin FITC -- HIF-1α. Yellow shows double staining of HIF-1α expression in SMC using. rhodamine.\
**Abbreviations:** FITC, fluorescein isothiocyanate; HIF-1α, hypoxia-inducible factor-1α; SMC, smooth muscle cell.](vhrm-10-523Fig1){#f1-vhrm-10-523}

![Immunofluorescence result of double stained NF-κB with HIF-1α.\
**Notes:** (**A**) NF-κB FITC. The color green shows NF-κB expression. (**B**) HIF-1α rhodamine. Red shows HIF-1α expression. (**C**) Double staining NF-κB FITC -- HIF-1α rhodamine. Yellow shows double staining expression of NF-κB and HIF-1α inside the nucleus.\
**Abbreviations:** FITC, fluorescein isothiocyanate; HIF-1α, hypoxia-inducible factor-1α; NF-κB, nuclear factor kappa beta.](vhrm-10-523Fig2){#f2-vhrm-10-523}

![Immunofluorescence staining result of iNOS in SMC, labeled with α-actin.\
**Notes:** (**A**) α-actin FITC. The color green shows α-actin expression (SMC marker). (**B**) iNOS rhodamine. Red shows iNOS expression. (**C**) Double stained α-actin with FITC-and iNOS with rhodamine. Yellow shows double staining expression of iNOS in SMC.\
**Abbreviations:** FITC, fluorescein isothiocyanate; iNOS, inducible nitric oxide synthase; SMC, smooth muscle cell.](vhrm-10-523Fig3){#f3-vhrm-10-523}

![Hematoxylin and eosin staining in aortic tissue of the rat models in various treatment groups.\
**Notes:** (**A**) MPEE 1: group with administration of 200 mg/kg BW doses of MPEE. (**B**) MPEE 2: group with administration of 400 mg/kg BW doses of MPEE. (**C**) MPEE 3: group with administration of 800 mg/kg BW doses of MPEE. (**D**) Normal diet group. (**E**) Hypercholesterol group. Red arrows show the newly formed vasa vasorum.\
**Abbreviations:** BW, body weight; MPEE, mangosteen pericarp ethanolic extract.](vhrm-10-523Fig4){#f4-vhrm-10-523}

###### 

Parameter measurement, ANOVA, and post hoc Duncan test for each treatment group

  Parameters                         Treatment groups   *P*-value                                                                                                                                                      
  ---------------------------------- ------------------ ------------------ --------------- ------------------ --------------- ------------------ --------------- ------------------ --------------- ------------------ ------
  Angiogenesis                                                                                                                                                                                                         
  • VEGFR-1 (pg/mL)                  16.0±0.4           15.7--16.9         12.9±1.7        10.6--15.4         15.9±1.6        13.0--17.5         15.2±2.2        12.2--18.2         13.9±1.4        12.3--15.7         0.04
  • Vasa vasorum (amount/HE slide)   20.5±2.2           18.0--23.0         3.7±1.6         2.0--6.0           5.8±1.4         4.0--7.0           3.5±0.5         3.0--4.0           2.2±1.4         1.0--4.0           0.00
  H~2~O~2~ (pg/mL)                   1.4±0.5            0.8--1.9           0.2±0.1         0.1--0.2           1.0±0.3         0.5--1.5           0.6±0.2         0.4--0.9           0.4±0.1         0.2--0.6           0.01
  HIF-1α (au)                        1,252.2±85.4       1,115.1--1,327.4   978.6±243.0     612.9--1,298.9     1,276.8±280.5   823.2--1,555.6     858.1±57.6      769.2--927.6       731.1±269.6     508.2--1,189.2     0.03
  NF-κB (au)                         1,953.2±80.5       1,842.9--2,087.2   1,655.3±315.1   1,364.5--2,146.6   1,902.4±58.8    1,822.6--1,982.2   1,426.2±187.9   1,167.9--1,692.6   1,343.5±260.7   1,132.3--1,767.9   0.01
  iNOS (au)                          1,276.8±169.0      1,006.6--1,458.7   849.8±78.3      736.2--987.9       950.7±252.1     654.2--1,321.8     660.1±209.3     467.9--991.2       574.6±198.6     309.8--849.0       0.00

**Abbreviations:** ANOVA, analysis of variance; au, ; BW, body weight; H~2~O~2~, hydrogen peroxide; HE, hematoxylin and eosin; HIF-1α, hypoxia-inducible factor-1α; iNOS, inducible nitric oxide synthase; min--max, minimum to maximum; MPEE, mangosteen pericarp ethanolic extract; NF-κB, nuclear factor kappa beta; SD, standard deviation; VEGFR-1, vascular endothelial growth factor receptor-1.
